ABSTRACT
Omics refers to the study of various relationships of biological molecules, their actions and roles, and the collective technologies that are used to explore them. It helps to study the processes involved in a particular disease and the mode of action of compounds. It is divided in to three categories-genomics, proteomics, and metabolomics. Large number of DNA sets can be sequenced to analyze the structure and function of genomes, proling whole mRNA genome, miRNA expression (transcriptomics), and epigenetic modications on the genome of mRNA (epigenomics). These are classied under genomics. It is, nowadays, no more a tedious job, courtesy of the sophisticated technologies available now that facilitate analysis of millions of sequences at once. The genetic approach toward a disease is an important aspect to know the underlying mechanism of the disease [1,2]. Computer technologies such as MRI and CT can help in the imaging
CONTENTS
26.1 Introduction ........................................................................................................................ 497 26.2 Omics Categories ............................................................................................................... 499
26.2.1 Genomics ................................................................................................................. 499 26.2.2 Proteomics ............................................................................................................... 499 26.2.3 Toxicogenomics ......................................................................................................500 26.2.4 Metabolomics ......................................................................................................... 501 26.2.5 Marine Omics ......................................................................................................... 501
26.3 Nanotherapy .......................................................................................................................502 26.3.1 Nanotherapy in Cancer and Clinical Care ......................................................... 502
26.3.1.1 Nanoparticles ...........................................................................................502 26.4 Nanoproteomics .................................................................................................................503
